This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its structure, featuring a trifluoromethoxy group, enhances its potential in developing drugs with improved metabolic stability and bioavailability. Researchers often employ it in the design of compounds that interact with specific receptors or enzymes in the central nervous system, making it valuable for studying conditions like epilepsy, depression, and chronic pain. Additionally, its chiral nature allows for the exploration of enantioselective interactions in drug development, contributing to the creation of more effective and targeted therapies.